Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
ARAUJO, Daniel Brito de
VILELA, Veronica Silva
BEZERRA, Mailze Campos
CUNHA, Bernardo Matos da
Citação
ADVANCES IN RHEUMATOLOGY, v.59, article ID 6, 12p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Recommendations of the Myopathy Committee of the Brazilian Society of Rheumatology for the management and therapy of systemic autoimmune myopathies (SAM). Main body: The review of the literature was done in the search for the Medline (PubMed), Embase and Cochrane databases including studies published until June 2018. The Prisma was used for the systematic review and the articles were evaluated according to the levels of Oxford evidence. Ten recommendations were developed addressing the management and therapy of systemic autoimmune myopathies. Conclusions: Robust data to guide the therapeutic process are scarce. Although not proven effective in controlled clinical trials, glucocorticoid represents first-line drugs in the treatment of SAM. Intravenous immunoglobulin is considered in induction for refractory cases of SAM or when immunosuppressive drugs are contra-indicated. Consideration should be given to the early introduction of immunosuppressive drugs. There is no specific period determined for the suspension of glucocorticoid and immunosuppressive drugs when individually evaluating patients with SAM. A key component for treatment in an early rehabilitation program is the inclusion of strength-building and aerobic exercises, in addition to a rigorous evaluation of these activities for remission of disease and the education of the patient and his/her caregivers.
Palavras-chave
Dermatomyositis, Guidelines, Polymyositis, Systemic autoimmune myopathies, Treatment
Referências
  1. Abdul-Aziz R, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0154-4
  2. Aggarwal R, 2016, ANN RHEUM DIS, V2017, P792
  3. Aggarwal R, 2016, RHEUMATOLOGY, V55, P991, DOI 10.1093/rheumatology/kev444
  4. Alexanderson H, 2014, J RHEUMATOL, V41, P1124, DOI 10.3899/jrheum.131145
  5. Allenbach Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133702
  6. Amato AA, 2011, ANN NEUROL, V70, P427, DOI 10.1002/ana.22477
  7. [Anonymous], 2009, OXFORD CTR EVIDENCE
  8. [Anonymous], 2017, HLTH SURV GUID
  9. Aymonier M, 2017, ANN DERMATOL VENER, V144, P279, DOI 10.1016/j.annder.2016.09.677
  10. Bachelez H, 1997, ARCH INTERN MED, V157, P1501, DOI 10.1001/archinte.157.13.1501
  11. Badrising Umesh A, 2017, J Neuromuscul Dis, V4, P327, DOI 10.3233/JND-170234
  12. Bertolucci F, 2014, EUR J PHYS REHAB MED, V50, P161
  13. Boehler JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183292
  14. Bolosiu HD, 1999, ADV EXP MED BIOL, V455, P349
  15. Bronner IM, 2006, ANN RHEUM DIS, V65, P1456, DOI 10.1136/ard.2005.045690
  16. Bruhler S, 2015, SWISS MED WEEKLY, V145
  17. BUNCH TW, 1981, ARTHRITIS RHEUM, V24, P45, DOI 10.1002/art.1780240107
  18. BUNCH TW, 1980, ANN INTERN MED, V92, P365, DOI 10.7326/0003-4819-92-3-365
  19. Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
  20. Chan MJ, 2018, J CLIN PHARM THER, V43, P256, DOI 10.1111/jcpt.12644
  21. Chang HK, 2003, J KOREAN MED SCI, V18, P131, DOI 10.3346/jkms.2003.18.1.131
  22. Chen F, 2015, INTERN MED J, V45, P641, DOI 10.1111/imj.12754
  23. Cherin P, 2002, ARTHRITIS RHEUM, V46, P467, DOI 10.1002/art.10053
  24. CHERIN P, 1994, J RHEUMATOL, V21, P1092
  25. Cooper C, 2016, MO J MATH SCI, V28, P1
  26. Dagher R, 2012, RHEUMATOL INT, V32, P711, DOI 10.1007/s00296-010-1653-5
  27. Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225
  28. Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1
  29. DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704
  30. Dastmalchi M, 2008, ANN RHEUM DIS, V67, P1670, DOI 10.1136/ard.2007.077974
  31. Davis Joshua S, 2003, Commun Dis Intell Q Rep, V27, P526
  32. Day J, 2017, SEMIN ARTHRITIS RHEU, V46, P642, DOI 10.1016/j.semarthrit.2016.11.001
  33. De Padilla CML, 2015, CLIN EXP RHEUMATOL, V33, P655
  34. de Souza FHC, 2017, CLIN EXP RHEUMATOL, V35, P766
  35. de Souza RC, 2017, CLIN EXP RHEUMATOL, V35, P1011
  36. Edge JC, 2006, ARCH DERMATOL, V142, P65, DOI 10.1001/archderm.142.1.65
  37. Enders FB, 2014, ARTHRITIS RHEUMATOL, V66, P2281, DOI 10.1002/art.38676
  38. Englund P, 2002, ARTHRITIS RHEUM, V46, P1044, DOI 10.1002/art.10140
  39. ESCALANTE A, 1993, J RHEUMATOL, V20, P1340
  40. Fathi M, 2012, J INTERN MED, V271, P589, DOI 10.1111/j.1365-2796.2011.02459.x
  41. Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1
  42. Frikha F, 2009, RHEUMATOLOGY, V48, P1166, DOI 10.1093/rheumatology/kep147
  43. Gerhart JL, 2010, J AM ACAD DERMATOL, V62, P957, DOI 10.1016/j.jaad.2009.07.042
  44. Gono T, 2014, RHEUMATOLOGY, V53, P2196, DOI 10.1093/rheumatology/keu258
  45. Gordon PA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003643.pub4
  46. Gottfried I, 2000, EUR J DERMATOL, V10, P29
  47. Guissa VR, 2012, CLIN EXP RHEUMATOL, V30, P583
  48. Guyatt GH, 2008, BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE
  49. Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
  50. HICKS JE, 1993, J RHEUMATOL, V20, P1399
  51. HIRANO F, 1993, INTERNAL MED, V32, P749, DOI 10.2169/internalmedicine.32.749
  52. Hoa SAT, 2017, SEMIN ARTHRITIS RHEU, V46, P488, DOI 10.1016/j.semarthrit.2016.07.014
  53. HOFFMAN GS, 1983, AM J MED, V75, P433, DOI 10.1016/0002-9343(83)90344-3
  54. Iannone F, 2006, J RHEUMATOL, V33, P1802
  55. Iberati A, 2009, BMJ-BRIT MED J, V339, pb2700, DOI 10.1136/BMJ.B2700
  56. Ibrahim F, 2015, RHEUMATOLOGY, V54, P1050, DOI 10.1093/rheumatology/keu442
  57. Ishizuka M, 2016, MOD RHEUMATOL, V26, P115, DOI 10.3109/14397595.2015.1054081
  58. Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705
  59. JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I
  60. Kadoya A, 1996, J RHEUMATOL, V23, P1186
  61. Kim HA, 1998, CLIN EXP RHEUMATOL, V16, P9
  62. Kobayashi N, 2015, J RHEUMATOL, V42, P2412, DOI 10.3899/jrheum.140977
  63. Krystufkova O, 2009, ANN RHEUM DIS, V68, P836, DOI 10.1136/ard.2008.091405
  64. Kubo M, 2000, RHEUMATOLOGY, V39, P632, DOI 10.1093/rheumatology/39.6.632
  65. Kuhn MA, 2013, OTOLARYNG CLIN N AM, V46, P1087, DOI 10.1016/j.otc.2013.08.006
  66. Lam CS, 2006, EUR J CLIN MICROBIOL, V25, P14, DOI 10.1007/s10096-005-0070-2
  67. Lambotte O, 2005, J RHEUMATOL, V32, P1369
  68. Leclair V, 2017, CURR OPIN RHEUMATOL, V29, P652, DOI 10.1097/BOR.0000000000000430
  69. Lems WF, 2015, ENDOCRINE, V49, P628, DOI 10.1007/s12020-015-0639-1
  70. Levine TD, 2005, ARTHRITIS RHEUM, V52, P601, DOI 10.1002/art.20849
  71. Li X, 2006, JCR-J CLIN RHEUMATOL, V12, P114, DOI 10.1097/01.rhu.0000221794.24431.36
  72. Loell I, 2011, J INTERN MED, V269, P243, DOI 10.1111/j.1365-2796.2010.02334.x
  73. Lundberg IE, 2017, ARTHRITIS RHEUMATOL, V69, P2271, DOI 10.1002/art.40320
  74. Mahler EAM, 2011, RHEUMATOLOGY, V50, P2206, DOI 10.1093/rheumatology/ker088
  75. Majithia V, 2005, RHEUMATOLOGY, V44, P386, DOI 10.1093/rheumatology/keh499
  76. Marie I, 2001, J RHEUMATOL, V28, P2230
  77. Marie I, 2011, SEMIN ARTHRITIS RHEU, V41, P48, DOI 10.1016/j.semarthrit.2010.08.003
  78. Mathur T, 2015, AM J THER, V22, P350, DOI 10.1097/MJT.0b013e3182987983
  79. Matsubara S, 1997, J NEUROIMMUNOL, V76, P75, DOI 10.1016/S0165-5728(97)00033-7
  80. Matz EL, 2017, UROLOGY, V100, P16, DOI 10.1016/j.urology.2016.07.030
  81. McHugh NJ, 2018, NAT REV RHEUMATOL, V14, P290, DOI 10.1038/nrrheum.2018.56
  82. Mira-Avendano IC, 2013, RESP MED, V107, P890, DOI 10.1016/j.rmed.2013.02.015
  83. Mitsunaka H, 2000, SCAND J RHEUMATOL, V29, P192
  84. Moerman M, 2002, EUR ARCH OTO-RHINO-L, V259, P1, DOI 10.1007/PL00007520
  85. Mok CC, 2007, J RHEUMATOL, V34, P1864
  86. Morganroth PA, 2010, ARTHRIT CARE RES, V62, P1496, DOI 10.1002/acr.20212
  87. Mosca M, 2000, CLIN EXP RHEUMATOL, V18, P451
  88. Munters LA, 2016, ARTHRITIS RHEUMATOL, V68, P1738, DOI 10.1002/art.39624
  89. Munters LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4263
  90. Munters LA, 2013, ARTHRIT CARE RES, V65, P1959, DOI 10.1002/acr.22068
  91. Murach KA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12973
  92. Nader GA, 2010, MOL MED, V16, P455, DOI 10.2119/molmed.2010.00016
  93. Nader GA, 2009, CURR OPIN RHEUMATOL, V21, P599, DOI 10.1097/BOR.0b013e3283319d53
  94. Naji P, 2010, NEUROL INDIA, V58, P58, DOI 10.4103/0028-3886.60398
  95. Nakashima Shoko, 2002, Ryumachi, V42, P895
  96. Narazaki M, 2011, RHEUMATOLOGY, V50, P1344, DOI 10.1093/rheumatology/ker152
  97. Newman E D, 1995, J Clin Rheumatol, V1, P99, DOI 10.1097/00124743-199504000-00007
  98. Nistala K, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4311
  99. Noss EH, 2006, J RHEUMATOL, V33, P1021
  100. Nozaki K, 2009, J NEUROL NEUROSUR PS, V80, P904, DOI 10.1136/jnnp.2008.161448
  101. Nzeusseu A, 1999, CLIN EXP RHEUMATOL, V17, P441
  102. Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754
  103. Oddis CV, 2005, ARTHRITIS RHEUM, V52, P2607, DOI 10.1002/art.21291
  104. Oddis CV, 1999, LANCET, V353, P1762, DOI 10.1016/S0140-6736(99)01927-3
  105. Oh TH, 2007, MAYO CLIN PROC, V82, P441, DOI 10.4065/82.4.441
  106. Olazagasti JM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0543-y
  107. Olazagasti JM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0075-2
  108. Papadopoulou D, 2014, RHEUMATOL INT, V34, P151, DOI 10.1007/s00296-013-2907-9
  109. Pinhata MM, 2015, CLIN EXP RHEUMATOL, V33, P310
  110. Pisoni CN, 2007, RHEUMATOLOGY, V46, P516, DOI 10.1093/rheumatology/kel336
  111. Qushmaq KA, 2000, J RHEUMATOL, V27, P2855
  112. Raghu P, 2015, AM J THER, V22, P244, DOI 10.1097/MJT.0000000000000175
  113. Ravn P, 2004, SCAND J INFECT DIS, V36, P499, DOI 10.1080/00365540410015222
  114. Reed AM, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0710-3
  115. Reed AM, 2012, ARTHRITIS RHEUM-US, V64, P4078, DOI 10.1002/art.34659
  116. Rider Lisa G., 2003, Journal of Rheumatology, V30, P603
  117. Saito E, 2008, MOD RHEUMATOL, V18, P34, DOI 10.1007/s10165-007-0013-0
  118. Sanei-Moghaddam A, 2013, BMJ CASE REP, V2013
  119. Santiago M, 2009, EUR J INTERN MED, V20, P744, DOI 10.1016/j.ejim.2009.09.001
  120. Schiopu E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3704
  121. Schrey A, 2017, J NEUROL SCI, V380, P142, DOI 10.1016/j.jns.2017.07.031
  122. Seshadri R, 2008, ARTHRIT RHEUM-ARTHR, V59, P989, DOI 10.1002/art.23829
  123. Shinjo SK, 2015, CLIN EXP RHEUMATOL, V33, P336
  124. Shinjo SK, 2012, VACCINE, V31, P202, DOI 10.1016/j.vaccine.2012.10.063
  125. Sanchez-Fernandez AS, 2013, REUMATOL CLIN, V9, P117, DOI 10.1016/j.reuma.2012.02.007
  126. Stern A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005590.pub3
  127. Tiffreau V, 2017, ARCH PHYS MED REHAB, V98, P227, DOI 10.1016/j.apmr.2016.09.125
  128. Tjarnlund A, 2018, ANN RHEUM DIS, V77, P55, DOI 10.1136/annrheumdis-2017-211751
  129. Uchino M, 2012, EUR NEUROL, V68, P117, DOI 10.1159/000338474
  130. Unger L, 2014, RHEUMATOLOGY, V53, P1630, DOI 10.1093/rheumatology/keu024
  131. Utsunomiya M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1206-8
  132. van Assen S, 2011, AUTOIMMUN REV, V10, P341, DOI 10.1016/j.autrev.2010.12.003
  133. van de Vlekkert J, 2010, NEUROMUSCULAR DISORD, V20, P382, DOI 10.1016/j.nmd.2010.03.011
  134. van der Kooi A J, 2014, Handb Clin Neurol, V119, P495, DOI 10.1016/B978-0-7020-4086-3.00032-1
  135. Varju C, 2003, CLIN REHABIL, V17, P83, DOI 10.1191/0269215503cr572oa
  136. Vencovsky J, 2000, SCAND J RHEUMATOL, V29, P95, DOI 10.1080/030097400750001897
  137. Villalba L, 1998, ARTHRITIS RHEUM-US, V41, P392, DOI 10.1002/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X
  138. Ward MM, 1999, ARTHRITIS RHEUM, V42, P780, DOI 10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M
  139. Wendling D, 2007, REV MED INTERNE, V28, P194, DOI 10.1016/j.revmed.2006.12.001
  140. Wiesinger GF, 1998, BRIT J RHEUMATOL, V37, P196
  141. WINKELMA.RK, 1968, MAYO CLIN PROC, V43, P545
  142. Wolfe RM, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0664-6
  143. Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5
  144. Yao L, 2016, RHEUMATOLOGY, V55, P441, DOI 10.1093/rheumatology/kev344
  145. Yu KH, 2011, CLIN RHEUMATOL, V30, P1595, DOI 10.1007/s10067-011-1840-0